Table 2 Characteristics of TB cases with PYD, HFYD and DQY Syndromes

Age, Age range (Mean ± SD)

18-75 (43.36 ± 14.62)

18-75 (45.18 ± 15.08)

18-75 (46.78 ± 14.44)

0.4051^a

Gender (female: male)

24/47

27/52

21/43

0.9924^b

Positive sputum smears, no. (%)

50 (70.42)

53 (67.09)

49 (76.56)

0.4619^b

Tuberculin skin test (>10 mm), no. (%)

40 (56.34)

47 (59.50)

41 (64.06)

0.6601^b

Smoking, no. (%)

30 (42.25)

37 (46.84)

30 (46.88)

0.8188^b

BCG vaccination, no. (%)

64 (90.14)

76 (96.20)

56 (87.5)

0.1537^b

FIB(g/L) (Mean ± SD)

4.18 ± 1.11

3.82 ± 1.28

3.70 ± 1.15

0.0653^a

PT(s) (Mean ± SD)

13.47 ± 1.45

13.15 ± 1.32

13.32 ± 1.27

0.3787^a

APTT(s) (Mean ± SD)

31.20 ± 4.39

30.44 ± 4.60

30.27 ± 4.04

0.4464^a

TT(s) (Mean ± SD)

14.42 ± 1.32

14.47 ± 1.13

14.78 ± 1.36

0.2483^a

Blood glucose (mmol/L) (Mean ± SD)

4.90 ± 0.64

5.04 ± 0.55

5.11 ± 1.74

0.5184^a

ESR (mm/h) (Mean ± SD)

11.15 ± 4.85

12.06 ± 5.91

13.72 ± 6.72

0.0388*^a

13.72 ± 6.72

0.0178*^a

CT scan

Degenerative lesions: cavity, caseous necrosis

18 (25.35)

35 (44.30)

20 (31.25)

0.0427*^b

Proliferative lesions

29 (40.85)

21 (26.58)

18 (28.13)

0.1307^b

Exudation and other inflammatory lesions

21 (29.58)

20 (25.32)

17 (26.56)

0.8365^b

Millet lesions

1 (1.41)

0 (0)

7 (10.94)

0.0013**^b

Pleural lesion

2 (2.82)

3 (3.80)

2 (3.13)

0.9419^b